Publication | Open Access
Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome
117
Citations
20
References
2020
Year
These findings suggest that continued ACEi/ARB use in hypertensive COVID-19 patients yields better clinical outcomes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1